Skip to main content
All lobbying filings

FIERCE GOVERNMENT RELATIONS

Lobbying for ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA) · Trade Organization for Generic Drug Manufacturers and Distributers

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · Senate · $60,000.00 income · posted Jan 20, 2026

Official filing document

 Bills named in this filing 9
  • S 43
    Skinny Labels, Big Savings Act
  • S 1041
    Affordable Prescriptions for Patients Act
  • S 1096
    Preserve Access to Affordable Generics and Biosimilars Act
  • S 1302
    Increasing Transparency in Generic Drug Applications Act
  • S 1414
    Expedited Access to Biosimilars Act
  • S 1954
    Biosimilar Red Tape Elimination Act
  • S 2296
    National Defense Authorization Act for Fiscal Year 2026
  • HR 1262
    Mikaela Naylon Give Kids a Chance Act
  • HR 3838
    Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 20…
 Lobbying activity 1
Pharmacy

Supply Chain, Drug Shortages, Tariffs, Patent Thickets, Patent Settlements, Generic Drugs, S.43 - Skinny Labels, Big Savings Act, S.1041 - Affordable Prescriptions for Patients Act, S.1096 - Preserve Access to Affordable Generics and Biosimilars Act, S.1302 - A Bill to Provide for Increased Transparency in Generic Drug Applications, S.1414 - Expedited Access to Biosimilars Act, S.1954 - Biosimilar Red Tape Reduction Act, S.2296 - National Defense Authorization Act for FY 2026, H.R.1262 - Give Kids a Chance Act, H.R.3838 - Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem